Longevity Health Holdings, Inc. Common Stock
XAGE
XAGE was delisted on the 11th of September, 2025.
2 hedge funds and large institutions have $5.61K invested in Longevity Health Holdings, Inc. Common Stock in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.11% less ownership
Funds ownership: 1.11% → 0% (-1.1%)
33% less funds holding
Funds holding: 3 → 2 (-1)
60% less capital invested
Capital invested by funds: $14.1K → $5.61K (-$8.44K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BSB
Bangor Savings Bank
Bangor,
Maine
|
-$819 |
| 2 |
CMU
Carnegie Mellon University
Pittsburgh,
Pennsylvania
|
-$3 |
XAGE Hedge Fund Activity: Q4 2025 in Review
2 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Longevity Health Holdings, Inc. Common Stock (XAGE) for Q4 2025, worth a combined $5.61K — down 60% from $14.1K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of XAGE and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Bangor Savings Bank, exiting entirely with an estimated $819 sold.
- 2 institutional investors held Longevity Health Holdings, Inc. Common Stock (XAGE) as of Q4 2025, down from 3 in Q3 2025.
- Funds reported $5.61K of Longevity Health Holdings, Inc. Common Stock stock for Q4 2025, down 60% quarter-over-quarter.
- 0 funds opened new Longevity Health Holdings, Inc. Common Stock positions in Q4 2025 and 1 closed out, a net change of -1 holder.
- The largest Longevity Health Holdings, Inc. Common Stock seller in Q4 2025 was Bangor Savings Bank, an estimated $819 sold.
Based on aggregated 13F filings for Q4 2025.